PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that Edward J. Quilty, the Company’s chief executive officer will present a corporate overview and update at the 11th Annual Needham Healthcare Conference taking place from April 3-4, 2012 at The New York Palace Hotel, New York City. The Company’s presentation will take place on Tuesday, April 3, 2012 at 1:20 p.m. ET.
To listen and view the presentation investors may visit the investor relations section of Derma Sciences’ website at www.dermasciences.com. An archived copy of the presentation will also be available on Derma Sciences’ website.
Derma Sciences is a medical technology company focused on three segments of the wound care marketplace: pharmaceutical wound care products, advanced wound care dressings and traditional dressings. Derma Sciences has successfully completed the Phase 2 clinical trial in diabetic foot ulcer healing with DSC127, an investigational pharmaceutical drug under development for accelerated wound healing and scar reduction, and is preparing to begin Phase 3 clinical trials. Its MEDIHONEY® product is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of indications, and was the focus of a positive large-scale, randomized controlled trial involving 108 subjects with leg ulcers. Other novel products introduced into the $14 billion global wound care market include XTRASORB® for better management of wound exudate, BIOGUARD® for infection prevention and TCC-EZ™ total contact cast for diabetic foot ulcer healing.
For more information please visit www.dermasciences.com.
Derma Sciences, Inc.
Executive Vice President, Global Marketing and Business Development
Lippert/Heilshorn & Associates
Kim Sutton Golodetz ([email protected])
Bruce Voss ([email protected])
Mackenzie Mills ([email protected])
KEYWORDS: United States North America New Jersey New York
INDUSTRY KEYWORDS: Health Clinical Trials Hospitals Medical Devices Pharmaceutical Other Health Research Other Science Science